During the meeting in Holzminden, CEO Dr Jean-Yves Parisot highlighted the company’s solid organic sales growth and highest profitability in ten years achieved during the 2025 financial year. Symrise reported consolidated sales of €4.9 billion and an adjusted EBITDA margin of 21.9%.
The company also emphasised progress in its ONE Symrise transformation strategy and the continued expansion of its Care & Wellness division, which focuses on integrated solutions for health, wellbeing and beauty markets.
In addition, shareholders approved the appointment of Eva Kienle, Claus-Oliver Schmidt and Jens Wellmann as new members of the Supervisory Board.
